Integral Health Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,000
Closed -$4.65M 91
2025
Q1
$4.65M Buy
+20,000
New +$4.85M 0.5% 55
2024
Q2
Sell
-20,000
Closed -$4.37M 92
2024
Q1
$4.37M Sell
20,000
-30,000
-60% -$6.61M 0.41% 68
2023
Q4
$11.4M Buy
+50,000
New +$10.5M 1.55% 26
2023
Q2
Sell
-23,280
Closed -$4.59M 88
2023
Q1
$4.59M Buy
+23,280
New +$4.79M 0.92% 42
2022
Q1
Sell
-23,280
Closed -$6.28M 81
2021
Q4
$6.28M Buy
+23,280
New +$5.76M 1.74% 23
2021
Q2
Sell
-29,100
Closed -$6.38M 82
2021
Q1
$6.38M Buy
+29,100
New +$5.84M 1.82% 18

Other funds holding LH

Integral Health Asset Management's LH Position: Q2 2025 in Review

Integral Health Asset Management sold out of Labcorp (LH) in Q2 2025, closing a stake of 20,000 shares — an estimated $4.65M sold.

Integral Health Asset Management first reported a position in LH in Q1 2021 and held it in 6 quarters. The position peaked at $11.4M in Q4 2023. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Integral Health Asset Management reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 20,000 Labcorp shares in Q2 2025, an estimated $4.65M.
  • Integral Health Asset Management first reported a position in Labcorp in Q1 2021 and held it in 6 quarters.
  • Integral Health Asset Management's Labcorp position peaked at $11.4M in Q4 2023.
  • 973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.